The Latest in AML

CLAM trial regimen shown safe, effective for r/r AML

April 17, 2020

COVID-19: Adjusting practice in acute leukemia care

April 1, 2020

COVID-19: ASTCT provides interim guidelines for transplantation

March 16, 2020

Second transplant a good salvage option for children with ALL, AML, or MDS

March 16, 2020

Accelerated fetal growth in boys associated with development of AML

March 12, 2020

Initial FLAG-Ida outperforms 7+3 for high-risk AML

February 24, 2020

AML

Survival for older AML patients better with HSCT from unrelated donors

February 8, 2020

9/11 responders show increased risk of leukemia, other cancers

January 14, 2020

Genomic profiling of AML and MDS yields prognostic clues

January 9, 2020

AML

Oral azacitidine: First maintenance therapy for AML

December 13, 2019

AML

Kidney function in African American AML patients not linked to reduced survival compared with whites

December 7, 2019

AML

Will TP53-mutated AML respond to immunotherapy?

November 18, 2019

Caspofungin bests fluconazole for antifungal prophylaxis in young AML patients

November 5, 2019

Hematopoietic cell transplant offers realistic cure in secondary AML

October 23, 2019

Adverse cytogenetics trump molecular risk in NPM1-mutated AML

October 15, 2019

AML